Reactive cutaneous capillary endothelial proliferation following camrelizumab monotherapy or combination therapy for multi-cancers: a large-scale pooled analysis of 10 studies in China
CONCLUSION: Although RCCEP occurred frequently with camrelizumab, most lesions were mild and self-limiting. The occurrence of RCCEP was strongly associated with the antitumor activity and survival of camrelizumab, both as monotherapy and in combination therapy.PMID:38606164 | PMC:PMC11008344 | DOI:10.1177/17588359241242607
Source: Adv Data - Category: Epidemiology Authors: Wenshu Qu Feng Wang Shukui Qin Yuqi Sun Chuanpei Huang Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | China Health | Clinical Trials | Epidemiology | Immunotherapy | Skin | Study | Toxicology